TMEM45A: A Potential Drug Target for Various Diseases (G55076)

Target Name: TMEM45A

NCBI ID: G55076

TMEM45A

TMEM45A: A Potential Drug Target for Various Diseases

TMEM45A, also known as DERP7, is a protein that is expressed in various tissues throughout the body. It is a member of the superfamily of transmembrane protein (TMEM) family 7, which is characterized by the presence of a transmembrane domain and a cytoplasmic tail. TMEM45A is of particular interest as it has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

TMEM45A is involved in various cellular processes that are critical for cell survival and function. One of its functions is to regulate the actinin cytoskeleton, which is responsible for the structural integrity of cells. TMEM45A is known to play a role in the regulation of actinin cytoskeleton dynamics and is involved in the assembly and disassembly of actinin filaments. This protein is also involved in the regulation of cell adhesion, which is critical for the maintenance of tissue structure and function.

In addition to its role in actinin cytoskeleton regulation, TMEM45A is also involved in the regulation of various signaling pathways that are critical for cell survival and function. One of its functions is to regulate the production of reactive oxygen species (ROS), which are highly reactive molecules that can cause damage to cells if not properly regulated. TMEM45A is known to play a role in the regulation of ROS production and has been shown to have antioxidant properties.

TMEM45A is also involved in the regulation of cellular apoptosis, which is a critical mechanism for cell death and removal. Apoptosis is a natural process that helps remove damaged or dysfunctional cells from the body, and it is critical for the maintenance of tissue homeostasis and regeneration. TMEM45A is known to play a role in the regulation of apoptosis and has been shown to have anti-apoptotic properties.

In addition to its functions in actinin cytoskeleton regulation, TMEM45A is also involved in the regulation of various signaling pathways that are critical for cell survival and function. One of its functions is to regulate the production of reactive oxygen species (ROS), which are highly reactive molecules that can cause damage to cells if not properly regulated. TMEM45A is known to play a role in the regulation of ROS production and has been shown to have antioxidant properties.

TMEM45A is also involved in the regulation of cellular apoptosis, which is a critical mechanism for cell death and removal. Apoptosis is a natural process that helps remove damaged or dysfunctional cells from the body, and it is critical for the maintenance of tissue homeostasis and regeneration. TMEM45A is known to play a role in the regulation of apoptosis and has been shown to have anti-apoptotic properties.

TMEM45A has also been identified as a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that TMEM45A is involved in the regulation of cancer cell growth and has been shown to have anti-tumor properties. In addition, TMEM45A has also been shown to play a role in the regulation of neurodegenerative diseases, such as Alzheimer's disease, and has been shown to have neuroprotective properties.

In conclusion, TMEM45A is a protein that is expressed in various tissues throughout the body and is involved in various cellular processes that are critical for cell survival and function. Its functions include the regulation of actinin cytoskeleton dynamics, the regulation of cell adhesion, the regulation of ROS production, and the regulation of cellular apoptosis. TMEM45A has also

Protein Name: Transmembrane Protein 45A

The "TMEM45A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM45A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets